Loading...
XNAS
BHST
Market cap98mUSD
Dec 04, Last price  
6.28USD
1D
-3.68%
1Q
-17.26%
IPO
9.22%
Name

Bioharvest Sciences Inc

Chart & Performance

D1W1MN
XNAS:BHST chart
P/E
—
P/S
4.32
EPS
—
Div Yield, %
—
Shrs. gr., 5y
40.58%
Rev. gr., 5y
158.55%
Revenues
25m
+98.77%
00040,000325,000449,000218,000396,0002,102,0005,498,00012,672,00025,188,000
Net income
-13m
L+2.78%
000-3,499,000-1,846,000-6,673,000-5,310,000-6,584,000-9,827,000-11,236,000-12,564,000-12,913,000
CFO
-7m
L-21.57%
00000-2,759,000-2,383,000-3,875,000-6,794,000-9,241,000-8,522,000-6,684,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

BioHarvest Sciences Inc., together with its subsidiaries, offers nutraceutical super fruits and cannabis verticals in Israel and internationally. Its plant cell growth technology produces the active secondary metabolites without the need to grow the plant itself. The company designs, develops, manufactures, and markets Vinia, a red grape powder nutraceutical product; and medical cannabis. BioHarvest Sciences Inc. is based in Vancouver, Canada.
URL
https://bioharvest.com/about/
IPO date
Aug 05, 2015
Employees
Domiciled in
CA
Incorporated in
CA

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122019‑042018‑122018‑042017‑042016‑04
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT